MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics.
Modag has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Modag's investors include Michael J. Fox Foundation, Massa Investment.
Modag is headquartered in Wendelsheim, Germany.
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics.
Modag is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Modag — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/modag. Accessed September 30, 2026.
VCBacked. (2025). Modag — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/modag
{{cite web |title=Modag — Funding & Investors |url=https://www.vcbacked.co/company/modag |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated